Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
12/21/2000 | WO2000038660A3 Use of bisphosphonates for the prevention and treatment of infectious processes |
12/21/2000 | DE19928146A1 New 3-benzylamino-benzothienopyrimidine derivatives inhibit phosphodiesterase V and are useful for treating cardiac insufficiency and impotence |
12/21/2000 | DE19928021A1 New nucleic acid encoding testis-specific calpain-11, useful for identifying specific inhibitors for treatment of fertility disorders |
12/21/2000 | CA2391364A1 47 human secreted proteins |
12/21/2000 | CA2382743A1 48 human secreted proteins |
12/21/2000 | CA2381322A1 Substituted heterocycle fused gamma-carbolines |
12/21/2000 | CA2377153A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
12/21/2000 | CA2376921A1 Nasal delivery of apomorphine |
12/21/2000 | CA2375878A1 Dithiepino[6,5-b]pyridines, and related compositions and methods |
12/21/2000 | CA2374909A1 Human intracellular signaling molecules |
12/21/2000 | CA2374239A1 Substituted heterocycle fused gamma-carbolines |
12/21/2000 | CA2373920A1 Substituted heterocycle fused gamma-carbolines |
12/20/2000 | EP1060187A1 S-substituted 11beta-benzaldoxime-estra-4,9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds |
12/20/2000 | CN1277613A Poly (ADP-ribose) polymerase ('PARP') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
12/20/2000 | CN1277612A Nitrogen-containing heterocyclic compounds, their production and use |
12/20/2000 | CN1277611A 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use |
12/20/2000 | CN1277261A Animal's castration vaccine gene and gene engineering body |
12/20/2000 | CN1277037A Medicine for cardiac and cerebral vascular diseases and hypogona dism and its preparation |
12/20/2000 | CN1277021A Impotence treating medicine spray and its preparation |
12/20/2000 | CN1059592C Medicine for treating hyperplasia of mammary glands and stopping pain |
12/20/2000 | CN1059580C Sikang yangsheng health-care tablet |
12/19/2000 | US6162817 Stroke therapy; brain disorders; crohn's disease |
12/19/2000 | US6162813 Antagonists of gonadotropin releasing hormone |
12/19/2000 | US6162444 Cosmetic or pharmaceutical compositions |
12/19/2000 | CA2145881C Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
12/19/2000 | CA2050291C Combination therapy for the treatment of estrogen sensitive diseases |
12/14/2000 | WO2000075375A1 26 human secreted proteins |
12/14/2000 | WO2000075186A1 Neuromedin b and somatostatin receptor agonists |
12/14/2000 | WO2000075139A2 Benzothiazinone and benzoxazinone compounds |
12/14/2000 | WO2000075126A1 Mycolactone and related compounds, compositions and methods of use |
12/14/2000 | WO2000075114A1 Beta2-adrenoceptor agonists |
12/14/2000 | WO2000075107A2 Bradykinin receptor antagonists |
12/14/2000 | WO2000074684A1 Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use |
12/14/2000 | WO2000074679A1 Substituted piperidines as melanocortin-4 receptor agonists |
12/14/2000 | WO2000074666A2 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidaemia and hyperuricaemia |
12/14/2000 | WO2000050562A3 Dna encoding snorf25 receptor |
12/14/2000 | WO2000048615A3 TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE) |
12/14/2000 | WO2000045841A3 Human papilloma virus vaccine formulations |
12/14/2000 | WO2000044399A3 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors |
12/14/2000 | WO2000006187A9 Modulation of apoptosis |
12/14/2000 | CA2751187A1 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl)acetic acid and derivatives thereof for treatment of hyperuricemia |
12/14/2000 | CA2383828A1 26 human secreted proteins |
12/14/2000 | CA2377369A1 Substituted piperidines as melanocortin-4 receptor agonists |
12/14/2000 | CA2376506A1 Neuromedin b and somatostatin receptor agonists |
12/14/2000 | CA2376010A1 Mycolactone and related compounds, compositions and methods of use |
12/14/2000 | CA2375734A1 Benzothiazinone and benzoxazinone compounds |
12/13/2000 | CN1276729A Heparin-binding growth factor (HBGF) polypeptides |
12/13/2000 | CN1276726A Method for treating hypercoagulable states or acquired protein C deficiency |
12/13/2000 | CN1276225A 'Chanhoukang' for postpartum recovery and its preparing process |
12/13/2000 | CN1276210A Application of carbonic anhydrase inhibitor in preparing male contraceptives |
12/13/2000 | CN1059446C Pharmaceutical composition and compounds for contraception, and their use |
12/13/2000 | CN1059346C Chinese herb medicine for external use of gynecopathy |
12/12/2000 | US6159989 Antagonists of gonadotropin releasing hormone |
12/12/2000 | US6159955 Use of hyaluronic acid and a NSAID for the manufacture of a medicament for the treatment of mucosal diseases |
12/12/2000 | US6159716 Amino acid sequence of serine/threonine kinase; antiulcer/ anticarcinogenic/antiarthritic agents; treatment of parkinson's/huntigton's diseases, tourette's syndrome, eating disorders, osteoporosis, allergies; diagnosis of disease |
12/12/2000 | US6159491 Prolonged release bioadhesive vaginal gel dosage form |
12/07/2000 | WO2000073449A1 Dna encoding snorf33 receptor |
12/07/2000 | WO2000073334A2 Human sorting nexins |
12/07/2000 | WO2000073330A2 Method and compositions relating to insulin resistance disorders |
12/07/2000 | WO2000072875A1 A method of prophylaxis and treatment and agents useful for same |
12/07/2000 | WO2000072871A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area |
12/07/2000 | WO2000072863A2 Uses of h-trek-1 polypeptides and polynucleotides encoding them |
12/07/2000 | WO2000072861A1 Pharmaceutical preparations of bioactive substances extracted from natural sources |
12/07/2000 | WO2000072855A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
12/07/2000 | WO2000072842A1 Nutritional supplements |
12/07/2000 | WO2000072832A2 Novel use of 1-[4-(cyanoindol-3yl)butyl]-4-(carbamoyl-benzofuran-5yl)-piperazine and its physiologically acceptable salts |
12/07/2000 | WO2000072815A1 Indole derivatives |
12/07/2000 | WO2000037100A3 Compositions and methods for reducing or preventing fertilization in fish and birds |
12/07/2000 | DE10027521A1 Verbesserung der Peyronie-Krankheit (Penisfibromatose) Improvement of Peyronie's disease (Penisfibromatose) |
12/07/2000 | CA2694866A1 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
12/07/2000 | CA2414094A1 Pharmaceutical preparations of bioactive substances extracted from natural sources |
12/07/2000 | CA2375850A1 Method and compositions relating to insulin resistance disorders |
12/07/2000 | CA2375047A1 Dna encoding snorf33 receptor |
12/07/2000 | CA2374310A1 Nutritional supplements |
12/07/2000 | CA2373726A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area |
12/07/2000 | CA2336262A1 Sorting nexins |
12/06/2000 | EP1057819A1 Phthalazine derivatives and remedies for erectile dysfunction |
12/06/2000 | EP1057480A2 Transdermal estrogen agonist-antagonist therapy |
12/06/2000 | EP1056886A1 Hla linked pre-eclampsia and miscarriage susceptibility gene |
12/06/2000 | EP1056849A1 Human smn-like protein |
12/06/2000 | EP1056769A1 15-methyl-cyclopropanosteroids and method for the production thereof |
12/06/2000 | EP1056760A1 36 human secreted proteins |
12/06/2000 | EP1056754A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone |
12/06/2000 | EP1056731A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone |
12/06/2000 | EP1056730A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone |
12/06/2000 | EP1056419A1 Treatment of female sexual dysfunction |
12/06/2000 | CN1275979A Isoquinolines as urokinase inhibitors |
12/06/2000 | CN1275383A Medicine for treating dysmenorrhea |
12/06/2000 | CN1059210C Process for preparation of 6-heterocyclic-4-amino-1,3,4,5-tetrahydrbenz [cd] indoles and acid additive salt used as medicine |
12/05/2000 | US6156786 2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome |
12/05/2000 | US6156783 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use |
12/05/2000 | US6156757 1,2,3,4-tetrahydro-benzofuro[3,2-C]pyridine derivatives |
12/05/2000 | US6156753 Local administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunction |
12/05/2000 | US6156752 Optically active 1,4-dihydropyridine compounds as bradykinin antagonists |
12/05/2000 | US6156742 Emergency contraceptive kit |
12/05/2000 | US6156734 Cardiovascular disorders |
12/05/2000 | US6156726 Voltage-gated calcium channel antagonist and method |
12/05/2000 | US6156523 Serine/threonine protein kinases |
12/05/2000 | US6156518 Methods of using DNA encoding human alpha 1 adrenergic receptors |
12/03/2000 | CA2308842A1 Amelioration of peyronie's disease |